Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Adaptive Biotechnologies revenue
Adaptive Biotechnologies's revenue is $179.0 million.
What is Adaptive Biotechnologies's revenue?
- Adaptive Biotechnologies's revenue growth from 2018 to 2024 is 221.5%.
- Adaptive Biotechnologies has 858 employees, and the revenue per employee ratio is $208,574.
- Adaptive Biotechnologies's peak quarterly revenue was $55.2M in 2022(q4).
- Adaptive Biotechnologies peak revenue was $185.3M in 2022.
- Adaptive Biotechnologies annual revenue for 2023 was 170.3M, -8.11% growth from 2022.
- Adaptive Biotechnologies annual revenue for 2024 was 179.0M, 5.1% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Adaptive Biotechnologies historical revenue
Adaptive Biotechnologies's peak revenue was $185.3M in 2022. The peak quarterly revenue was $55.2M in 2022(q4).
Adaptive Biotechnologies's revenue increased from $55.7m in 2018 to $179.0M currently. That's a 221.5% change in annual revenue.
Adaptive Biotechnologies annual revenue
Adaptive Biotechnologies annual revenue over time
| Fiscal year / year | Adaptive Biotechnologies revenue |
|---|---|
| 2018 | $55.7M |
| 2019 | $85.1M |
| 2020 | $98.4M |
| 2021 | $154.3M |
| 2022 | $185.3M |
| 2023 | $170.3M |
| 2024 | $179.0M |
Rate Adaptive Biotechnologies' financial transparency
Adaptive Biotechnologies annual growth
Adaptive Biotechnologies saw the greatest revenue growth in 2021, when revenue increased by 56.88%.
Adaptive Biotechnologies had the lowest revenue growth in 2020, when revenue changed by 15.65%.
Adaptive Biotechnologies annual growth rate over time
| Year | Adaptive Biotechnologies growth |
|---|---|
| 2019 | 53%↑ |
| 2020 | 16%↑ |
| 2021 | 57%↑ |
| 2022 | 20%↑ |
| 2023 | -8%↓ |
| 2024 | 5%↑ |
Adaptive Biotechnologies quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Adaptive Biotechnologies quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | $22.1M | $26.1M | $24.2M |
| 2020 | $20.9M | $21.0M | $26.3M | $30.2M |
| 2021 | $38.4M | $38.5M | $39.5M | $37.9M |
| 2022 | $38.6M | $43.7M | $47.8M | $55.2M |
| 2023 | $37.6M | $48.9M | $37.9M | $45.8M |
| 2024 | $41.9M | $43.2M | $46.4M | $47.5M |
Adaptive Biotechnologies jobs nearby
Do you work at Adaptive Biotechnologies?
Did Adaptive Biotechnologies meet its revenue projections?
Adaptive Biotechnologies financing
Adaptive Biotechnologies received early financing of $4.5M on 2010-03-24.
| Series | Round size | Date |
|---|---|---|
| Series A | $4.6M | 03/2010 |
| Series B | $5.8M | 06/2011 |
| Grant | $2.5M | 09/2013 |
| Series C | $5M | 04/2014 |
| Series D | $100M | 04/2014 |
| Series E | $94M | 01/2015 |
| Series F | $195M | 05/2015 |
Adaptive Biotechnologies investors
| Investors | Security type |
|---|---|
| Viking Global Investors | Series C |
| Viking Global Investors | Series D |
| Senator Investment Group LP | Series F |
| MATRIX CAPITAL MANAGEMENT CO | Series F |
| Tiger Management | Series F |
| Rock Springs Capital | Series F |
Adaptive Biotechnologies competitors
Adaptive Biotechnologies's top competitor, Veracyte, earned an annual revenue of $445.8M.
Adaptive Biotechnologies's smallest competitor is Oragenics with revenue of $1.1M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Veracyte | - | $445.8M | 270 | - |
| Aura Biosciences | - | $2.1M | 33 | - |
| Mirati Therapeutics | - | $12.4M | 418 | - |
| INmune Bio | - | $14,000 | 5 | - |
| Corbus Pharmaceuticals | - | $881,705 | 76 | - |
| Seres Therapeutics | - | $144.9M | 145 | - |
| Vedanta Biosciences | - | $8.0M | 99 | - |
| Catalyst Biosciences | - | $105.8M | 21 | - |
| Alcresta Therapeutics | - | $6.2M | 36 | - |
| Repertoire Immune Medicines | - | $5.9M | 175 | - |
Adaptive Biotechnologies revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Adaptive Biotechnologies highest paying jobs
Zippia gives an in-depth look into the details of Adaptive Biotechnologies, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Adaptive Biotechnologies. The employee data is based on information from people who have self-reported their past or current employments at Adaptive Biotechnologies. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Adaptive Biotechnologies. The data presented on this page does not represent the view of Adaptive Biotechnologies and its employees or that of Zippia.
Adaptive Biotechnologies may also be known as or be related to ADAPTIVE BIOTECHNOLOGIES CORP, Adaptive Biotechnologies, Adaptive Biotechnologies Corp, Adaptive Biotechnologies Corp. and Adaptive Biotechnologies Corporation.